Steven L Basta is President and CEO of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 41,625 shares of PHAT, which is worth approximately $594,405. The most recent transaction as insider was on Sep 25, 2025, when has been sold 48,375 shares (Common Stock) at a price of $11.66 per share, resulting in proceeds of $564,052. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.6K
n/a 3M change
n/a 12M change
Total Value Held $594,405

Steven L Basta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2025
SELL
Payment of exercise price or tax liability
$564,052 $11.66 p/Share
48,375 Reduced 53.75%
41,625 Common Stock
Sep 25 2025
BUY
Exercise of conversion of derivative security
-
90,000 Added 50.0%
90,000 Common Stock

Also insider at

VIVE
VIVEVE MEDICAL, INC. Healthcare
VYNE
VYNE Therapeutics Inc. Healthcare
SLB

Steven L Basta

President and CEO
Bridgewater, NJ

Track Institutional and Insider Activities on PHAT

Follow Phathom Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAT shares.

Notify only if

Insider Trading

Get notified when an Phathom Pharmaceuticals, Inc. insider buys or sells PHAT shares.

Notify only if

News

Receive news related to Phathom Pharmaceuticals, Inc.

Track Activities on PHAT